Global X Genomics & Biotechnology ETF (GNOM)Health | Exchange Traded Fund | NasdaqGM
47.59 USD
+1.38
(2.987%)
⇧
(April 17, 2026, 1:10 p.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ★★★☆☆ | Dividends: ★★★☆☆ |
Hot Take | April 11, 2026, 4:15 p.m. EDT
GNOM has shown some short-term volatility, with recent price movements hovering around the 44.0 range. While the dividend yield is decent at 1.43%, the recent dividend history is inconsistent, which may affect long-term appeal. The forecasting model suggests a slight downward trend in the short term, but the options data does not provide a strong consensus. Investors should consider the ETF's exposure to the biotechnology sector and the broader market sentiment before making decisions. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.076173 |
| AutoARIMA | 0.078994 |
| AutoETS | 0.079157 |
| MSTL | 0.083235 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 50% |
| H-stat | 4.06 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.373 |
| Excess Kurtosis | -0.75 |
As of April 11, 2026, 4:15 p.m. EDT: The options activity suggests mixed sentiment. For the near-term expiration (2026-05-15), there is significant open interest in puts at strikes below the current price, indicating potential bearish bias. However, calls are also showing some activity, particularly at the 45.0 strike, which could suggest a bullish outlook. The low volatility and open interest in puts may indicate some speculative activity around potential downside, but the overall options data does not strongly signal a clear direction.
| Last Yield | 1yr Yield | 3yr Avg | 5yr Avg |
|---|---|---|---|
| 1.30% | 1.39% | 0.46% | 0.29% |
| Date | Dividend | Yield % |
|---|---|---|
| 2025-12-30 | 0.591 | 1.295768 |
| 2025-06-27 | 0.032 | 0.096460 |
| 2021-12-30 | 0.028 | 0.035518 |
| 2020-12-30 | 0.128 | 0.133826 |
| Attribute | Value |
|---|---|
| All Time High | 113.8 |
| All Time Low | 11.49 |
| Ask | 47.78 |
| Ask Size | 5 |
| Average Daily Volume10 Day | 4,440 |
| Average Daily Volume3 Month | 8,962 |
| Average Volume | 8,962 |
| Average Volume10Days | 4,440 |
| Beta3 Year | 1.8 |
| Bid | 46.95 |
| Bid Size | 5 |
| Category | Health |
| Crypto Tradeable | 0 |
| Currency | USD |
| Custom Price Alert Confidence | HIGH |
| Day High | 47.71 |
| Day Low | 47.0 |
| Dividend Yield | 1.43 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 45.14268 |
| Fifty Day Average Change | 2.4478188 |
| Fifty Day Average Change Percent | 0.054224044 |
| Fifty Two Week Change Percent | 51.408913 |
| Fifty Two Week High | 51.42 |
| Fifty Two Week High Change | -3.8294983 |
| Fifty Two Week High Change Percent | -0.07447488 |
| Fifty Two Week Low | 29.44 |
| Fifty Two Week Low Change | 18.1505 |
| Fifty Two Week Low Change Percent | 0.6165251 |
| Fifty Two Week Range | 29.44 - 51.42 |
| First Trade Date Milliseconds | 1,554,903,000,000 |
| Five Year Average Return | -0.1207614 |
| Full Exchange Name | NasdaqGM |
| Fund Family | Global X Funds |
| Fund Inception Date | 1,554,422,400 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Has Pre Post Market Data | 1 |
| Language | en-US |
| Legal Type | Exchange Traded Fund |
| Long Business Summary | The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified. |
| Long Name | Global X Genomics & Biotechnology ETF |
| Market | us_market |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_605753422 |
| Nav Price | 46.31 |
| Net Assets | 49,206,136.0 |
| Net Expense Ratio | 0.5 |
| Open | 47.0 |
| Phone | +1 8884938631 |
| Previous Close | 46.21 |
| Price Hint | 2 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | ETF |
| Region | US |
| Regular Market Change | 1.3805008 |
| Regular Market Change Percent | 2.9874504 |
| Regular Market Day High | 47.71 |
| Regular Market Day Low | 47.0 |
| Regular Market Day Range | 47.0 - 47.71 |
| Regular Market Open | 47.0 |
| Regular Market Previous Close | 46.21 |
| Regular Market Price | 47.5905 |
| Regular Market Time | 1,776,445,850 |
| Regular Market Volume | 2,560 |
| Short Name | Global X Genomics & Biotechnolo |
| Source Interval | 15 |
| Symbol | GNOM |
| Three Year Average Return | -0.022203099 |
| Total Assets | 49,206,136 |
| Tradeable | 0 |
| Trailing Peg Ratio | None |
| Trailing Three Month Nav Returns | -3.93061 |
| Trailing Three Month Returns | -3.93061 |
| Triggerable | 1 |
| Two Hundred Day Average | 42.353374 |
| Two Hundred Day Average Change | 5.2371254 |
| Two Hundred Day Average Change Percent | 0.123653084 |
| Type Disp | ETF |
| Volume | 2,560 |
| Yield | 0.0143 |
| Ytd Return | -3.93061 |